Nuvisan

Meet Nuvisan at Frontiers in Medicinal Chemistry 2025! Our scientists Felix Pape and Ludwig Zorn, along with our Business Development Manager, Watchara Sirsisko, will be attending the Frontiers in Medicinal Chemistry conference—an annual event hosted by the GDCh Division of Medicinal Chemistry—in Erlangen, Germany, from April 1–4. Are you attending the conference? Would you like to discuss your specific needs with our experts? Our team is ready to explore tailored solutions to support your drug discovery efforts. See you next week! #MedicinalChemistry #DrugDiscovery #FIMC2025 #Nuvisan #ScienceCRO

𝗥𝗲𝗳𝗿𝗲𝘀𝗵𝗲𝗱 𝗯𝗿𝗮𝗻𝗱 𝗮𝗻𝗱 𝘂𝘀𝗲𝗿 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 𝗰𝗼𝗺𝗶𝗻𝗴 𝘀𝗼𝗼𝗻   Nuvisan is about to launch our redesigned website for more seamless access to information essential to our clients’ efforts to bring therapeutics to life. The new site also features a bold and vibrant redesigned logo and brand experience. 𝗛𝗲𝗿𝗲’𝘀 𝘄𝗵𝗮𝘁 𝘁𝗼 𝗹𝗼𝗼𝗸 𝗳𝗼𝗿𝘄𝗮𝗿𝗱 𝘁𝗼:  ·   A redesigned, user-friendly website tailored to your needs  ·   A modernised brand experience that truly reflects the innovation and confidence Nuvisan offers our clients  ·   The same trusted services and dedicated team you know and rely on, now supported by the global reach and resources of ALS. Look for our launch announcement soon to experience the new 𝗻𝘂𝘃𝗶𝘀𝗮𝗻.𝗰𝗼𝗺.  #Nuvisan #ScienceCRO

Oncology therapeutics is a multidisciplinary field, and chemists have played—and continue to play—a crucial role in cancer research. Dr. Norbert Schmees is a highly experienced medicinal chemist and leads a team of 25 scientists (from Scientist 1 to Senior Principal Scientist level) and lab professionals. With 25 years of experience in pharmaceutical research and process development, he focuses on therapeutic areas such as oncology (immune-oncology, epigenetics), inflammation, and female contraception. His expertise spans diverse target classes, including nuclear receptors, kinases, GPCRs, and epigenetic readers and writers. From April 25–30, Norbert will be joining the Nuvisan team at AACR 2025 in Chicago. Interested in discussing immune-oncology further? Connect with Norbert on LinkedIn! You’re also welcome to visit us at booth #3156. #Oncology #AACR2025 #DrugDiscovery #ScienceCRO #Nuvisan

🌟 Exciting News from ACS Spring 2025! 🌟 We’re thrilled to showcase our onsite team at the ACS Spring 2025 Conference in San Diego, where we’ll be connecting with industry leaders, innovators, and researchers driving the future of science. This is a fantastic opportunity to explore cutting-edge advancements, exchange insights, and demonstrate how Nuvisan is shaping the landscape of drug discovery and development. 📍 Visit us at our booth #3128 to learn more about our chemistry expertise, meet our team, and discover how we can support your research goals. Whether you’re looking for collaboration opportunities or simply want to chat with our experts, we’re here for you! #ACSSpring2025 #Nuvisan #LifeSienceChemistry #DrugDiscovery #ScienceCRO

🚀 Exciting Times at SOT 2025 🚀 We’re live at one of the most prestigious toxicology conferences in Orlando, Florida until March 20th, and the energy is absolutely amazing! Our team is excited to connect, learn, and contribute to the discussions shaping the future of toxicology. 💡 What we’re looking forward to: ✅ Engaging keynotes from industry leaders ✅ Thought-provoking panel discussions ✅ Exploring the latest innovations and trends ✅ Connecting with like-minded professionals and partners If you’re here, let’s connect! Stop by our booth #1352, or feel free to reach out - we'd love to chat. See you there! #SOT2025 #Nuvisan #Innovation #Networking #Toxicology

One of the largest oncology conferences, AACR 2025, is taking place in Chicago from April 25–30! This global event brings together scientists to showcase cutting-edge oncology research and engage in discussions that drive therapeutic innovation forward. 🤚 Of course, Nuvisan’s scientists will be there! Today, we’re excited to introduce Dr. Barbara Nicke, Head of Therapeutics Research at Nuvisan. A trained biochemist and cell biologist, Barbara has extensive expertise in functional genomics and drug discovery. She leads a team dedicated to supporting clients at all stages of drug development by identifying and generating disease-relevant in vitro models and assays. 💬 If you’d like to discuss your project with Barbara, feel free to connect with her on LinkedIn or request a meeting at hello@nuvisan.com. #Oncology #AACR2025 #DrugDiscovery #ScienceCRO #Nuvisan

🎉 16,000 followers and counting! 🎉 We are thrilled to celebrate this incredible milestone with all of you—our valued customers, partners, and supporters. Your engagement, feedback, and trust continue to drive us forward every day. This achievement is more than just a number; it’s a testament to the vibrant community we are building together. Thank you for being part of our journey! 🚀 Here’s to growing, innovating, and making an impact—together. #Nuvisan #ScienceCRO #16KStrong #Gratitude #DrugDiscovery #DrugDevelopment

Meet Us at Booth #3128 at ACS Spring 2025! Our chemistry experts David Schaller and Nico Bräuer will be joining our BD William Thomas at the American Chemical Society Spring Conference from March 23-27 in San Diego! This is a great opportunity to share our latest research and development and discuss your chemistry needs. Haven’t booked a meeting yet? Before our schedule fills up, secure a time slot here-> https://lnkd.in/eYaYJZ9w We look forward to having a conversation with you at ACS Spring 2025!  #ACS2025 #LifeScienceChemisry #DrugDiscovery #Nuvisan #ScienceCRO

🔬 And the countdown begins! One of the most prestigious toxicology conferences, SOT 2025, is coming soon to Orlando from March 16-20, 2025! Joining us will be Dr. med. vet. Burkhard Flick Flick, Head of Toxicology, along with our dedicated Business Development team: William Thomas, Stephanie Urschel PhD. and Olivier Baverey. We invite you to visit us at Booth #1352 to explore our comprehensive toxicology expertise and discover how our tailored solutions support innovative drug development 📅 Schedule a meeting with our experts here: https://lnkd.in/diTTDfxd 🤝 See you in Orlando! #2025SOT #ToxExpo #Toxicology #DrugDevelopment #Nuvisan #ScienceCRO

🚀 Enhancing Your Project with Our New XRPD Equipment! We are pleased to announce that we now offer expanded support for polymorph screening, API release and stability studies under both GMP and non-GMP environments with our newly added XRPD (D6-Phaser) equipment. With this newly added capability, our highly experienced scientists can efficiently assist you in selecting and controlling the solid-state properties of your API, ensuring optimal development outcomes. 💬 Get in touch with us for your API project: hello@nuvisan.com 👉 Learn more about our chemical development capabilities: https://lnkd.in/eAEsnC3n #XRPD #API #Polymorph #Nuvisan #ScienceCRO #DrugDevelopment